Clinical Trial Update: Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

View source ↗

Summary

A clinical trial at Abramson Cancer Center investigates the effects of immune checkpoint inhibitors on the coronary microvasculature, with attention to potentia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Coronary Microvascular Dysfunction
• Non-small Cell Lung Cancer

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Coronary Microvascular Dysfunction, Cardiotoxicity | Status: ENROLLING_BY_INVITATION